Researchers have developed an AI model that can predict cancer mutations from routine pathology slides, improving treatment decisions for patients.
The AI model can accurately predict genetic mutations like EGFR directly from pathology slides, potentially reducing the need for rapid genetic testing in some cases.
This AI model offers early detection of mutations, conserves tissue by avoiding some rapid tests, and facilitates faster treatment decisions without compromising quality of care.
The study demonstrates the potential of AI to streamline clinical decision-making, save resources, and expedite access to targeted therapies for cancer patients.